391 related articles for article (PubMed ID: 18949416)
1. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
2. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
3. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
5. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
6. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
7. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
9. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
10. [Multivariate analysis of prognosis in gastrointestinal stromal tumor].
Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Cheng SJ; Liu XY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):598-601. PubMed ID: 16438868
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
Bai YK; Shao YF; Cao WL; Shi SS; Yu LW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
[TBL] [Abstract][Full Text] [Related]
14. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of gastrointestinal stromal tumors of the stomach].
Hillemanns M; Päsold S; Böttcher K; Höfler H
Verh Dtsch Ges Pathol; 1998; 82():261-6. PubMed ID: 10095444
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
17. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
Rudolph P; Chiaravalli AM; Pauser U; Oschlies I; Hillemanns M; Gobbo M; Marichal M; Eusebi V; Höfler H; Capella C; Klöppel G
Virchows Arch; 2002 Sep; 441(3):238-48. PubMed ID: 12242520
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]